Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Coffee consumption and risk of myocardial infarction: a dose-response meta-analysis of observational studies.

Mo L, Xie W, Pu X, Ouyang D.

Oncotarget. 2018 Jan 4;9(30):21530-21540. doi: 10.18632/oncotarget.23947. eCollection 2018 Apr 20.

2.

Beneficial Role of Coffee and Caffeine in Neurodegenerative Diseases: A Minireview.

Sc Y, Muralidhara.

AIMS Public Health. 2016 Jun 20;3(2):407-422. doi: 10.3934/publichealth.2016.2.407. eCollection 2016. Review.

3.

Acute doses of caffeine shift nervous system cell expression profiles toward promotion of neuronal projection growth.

Yu NY, Bieder A, Raman A, Mileti E, Katayama S, Einarsdottir E, Fredholm BB, Falk A, Tapia-Páez I, Daub CO, Kere J.

Sci Rep. 2017 Sep 13;7(1):11458. doi: 10.1038/s41598-017-11574-6.

4.

Fatigue-related impairments in oculomotor control are prevented by norepinephrine-dopamine reuptake inhibition.

Connell CJ, Thompson B, Turuwhenua J, Srzich A, Gant N.

Sci Rep. 2017 Feb 15;7:42726. doi: 10.1038/srep42726.

5.

Caffeine and sleep-deprivation mediated changes in open-field behaviours, stress response and antioxidant status in mice.

Onaolapo JO, Onaolapo YA, Akanmu AM, Olayiwola G.

Sleep Sci. 2016 Jul-Sep;9(3):236-243. doi: 10.1016/j.slsci.2016.10.008. Epub 2016 Nov 12.

6.

Exercise-Induced Fatigue and Caffeine Supplementation Affect Psychomotor Performance but Not Covert Visuo-Spatial Attention.

Connell CJ, Thompson B, Kuhn G, Gant N.

PLoS One. 2016 Oct 21;11(10):e0165318. doi: 10.1371/journal.pone.0165318. eCollection 2016.

7.

Engineering a microbial platform for de novo biosynthesis of diverse methylxanthines.

McKeague M, Wang YH, Cravens A, Win MN, Smolke CD.

Metab Eng. 2016 Nov;38:191-203. doi: 10.1016/j.ymben.2016.08.003. Epub 2016 Aug 9.

8.

Fatigue related impairments in oculomotor control are prevented by caffeine.

Connell CJ, Thompson B, Kuhn G, Claffey MP, Duncan S, Gant N.

Sci Rep. 2016 May 25;6:26614. doi: 10.1038/srep26614.

9.

Caffeine-Induced Suppression of GABAergic Inhibition and Calcium-Independent Metaplasticity.

Isokawa M.

Neural Plast. 2016;2016:1239629. doi: 10.1155/2016/1239629. Epub 2016 Jan 14.

10.

Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.

Xu K, Di Luca DG, Orrú M, Xu Y, Chen JF, Schwarzschild MA.

Neuroscience. 2016 May 13;322:129-37. doi: 10.1016/j.neuroscience.2016.02.035. Epub 2016 Feb 22.

11.

Lifespan Extension Induced by Caffeine in Caenorhabditis elegans is Partially Dependent on Adenosine Signaling.

Bridi JC, Barros AG, Sampaio LR, Ferreira JC, Antunes Soares FA, Romano-Silva MA.

Front Aging Neurosci. 2015 Dec 8;7:220. doi: 10.3389/fnagi.2015.00220. eCollection 2015.

12.

A Methodological Discussion of Caffeine Research and Animal Avoidance Behavior.

Kennedy AE, Grimes LM, Labaton RS, Hine JF, Warzak WJ.

J Caffeine Res. 2015 Dec 1;5(4):176-186.

13.

Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice.

Szopa A, Poleszak E, Wyska E, Serefko A, Wośko S, Wlaź A, Pieróg M, Wróbel A, Wlaź P.

Naunyn Schmiedebergs Arch Pharmacol. 2016 Feb;389(2):211-21. doi: 10.1007/s00210-015-1189-z. Epub 2015 Nov 27.

14.

Caffeine stimulates locomotor activity in the mammalian spinal cord via adenosine A1 receptor-dopamine D1 receptor interaction and PKA-dependent mechanisms.

Acevedo J, Santana-Almansa A, Matos-Vergara N, Marrero-Cordero LR, Cabezas-Bou E, Díaz-Ríos M.

Neuropharmacology. 2016 Feb;101:490-505. doi: 10.1016/j.neuropharm.2015.10.020. Epub 2015 Oct 19.

15.

Role for Rab10 in Methamphetamine-Induced Behavior.

Vanderwerf SM, Buck DC, Wilmarth PA, Sears LM, David LL, Morton DB, Neve KA.

PLoS One. 2015 Aug 20;10(8):e0136167. doi: 10.1371/journal.pone.0136167. eCollection 2015.

16.

Osteogenic potential of osteoblasts from neonatal rats born to mothers treated with caffeine throughout pregnancy.

Reis AM, Ribeiro LG, Ocarino Nde M, Goes AM, Serakides R.

BMC Musculoskelet Disord. 2015 Feb 4;16:10. doi: 10.1186/s12891-015-0467-8.

17.

The combined effect of caffeine and ornithine on the mood of healthy office workers.

Misaizu A, Kokubo T, Tazumi K, Kanayama M, Miura Y.

Prev Nutr Food Sci. 2014 Dec;19(4):367-72. doi: 10.3746/pnf.2014.19.4.367. Epub 2014 Dec 31.

18.

Effects of 28-days ingestion of a slow-release energy supplement versus placebo on hematological and cardiovascular measures of health.

Wells AJ, Hoffman JR, Gonzalez AM, Beyer KS, Jajtner AR, Townsend JR, Oliveira LP, Fukuda DH, Fragala MS, Stout JR.

J Int Soc Sports Nutr. 2014 Dec 10;11(1):59. doi: 10.1186/s12970-014-0059-2. eCollection 2014.

19.

Caffeinated Alcoholic Beverages - An Emerging Trend in Alcohol Abuse.

Franklin KM, Hauser SR, Bell RL, Engleman EA.

J Addict Res Ther. 2013 Aug 20;Suppl 4. pii: S4-012.

20.

Cardiac arrest: a case-based review.

Yan L, Huang Y, Li SS.

World J Emerg Med. 2014;5(3):171-4. doi: 10.5847/wjem.j.1920-8642.2014.03.002. Review.

Supplemental Content

Support Center